Explore the transformative impact of cell and gene therapies on the current standard of care for patients with autoimmune disease.

This webinar will delve into the rapid advancements in clinical development across a variety of disease states, highlighting unique challenges and how it compares with development in oncology. Learn how to enhance site readiness and patient centricity and discover the importance of early planning and data-driven decisions in the successful development of cell and gene therapies in this dynamic space.

Register for this webinar today to gain insights into the advancements and challenges of developing cell and gene therapies for autoimmune diseases.

Key take-aways:

• Understand the challenges associated with these indications, the advantages of early planning and the data-driven decisions crucial for successful therapeutic advancements
• Utilize the knowledge gained from oncological studies to progress the advancement of cell therapies and help prepare clinical sites for the complexities of these trials
• Validate how a patient-focused approach benefits in the development and implementation of cell and gene therapies
• Discover how efficient operational models and expert cross-functional CAGT teams can reduce complexity and accelerate clinical trials

Speakers:

Erin Finot, MS, MBA, Vice President, Immuno-Oncology and Cell & Gene Therapy

Jessica Knight-Perry, MD, MSc, Senior Medical Director, Strategy Lead, Cell and Gene Therapy Center of Excellence

Emily Smith, Director, Therapeutic Strategy, Cell and Gene Therapy Center of Excellence

For more information and to register, click here.